RTW INVESTMENTS, LP Diversified Active

Location: New York, NY

CIK: 0001493215 · Show all filings

Period: Q4 2017 (← Previous) (Next →)

Filing Date: Feb 28, 2018

Total Value: $599M (100.0% shares, 0.0% debt)

Holdings (32)

PTCT PTC Therapeutics Inc 11.5%

Value $68.89M Shares 4,130,115 Est. Cost $13.46 Unrealized +25.7%

RGNX Regenxbio Inc 8.7%

Value $51.91M Shares 1,561,210 Est. Cost $20.73 Unrealized +45.4%

BMY Bristol-Myers Squibb Co 8.6%

Value $51.44M Shares 839,452 Est. Cost $42.11 Unrealized +10.3%

ALNY Alnylam Pharmaceuticals Inc 7.6%

Value $45.58M Shares 358,774 Est. Cost $75.05 Unrealized +67.4%

— Dicerna Pharmaceuticals Inc 7.4%

Value $44.14M Shares 5,035,662 Est. Cost $10.56 Unrealized —

— Achillion Pharmaceuticals Inc 6.5%

Value $39.02M Shares 13,546,902 Est. Cost $3.82 Unrealized —

— La Jolla Pharmaceutical Co 5.7%

Value $34.21M Shares 1,063,170 Est. Cost $25.47 Unrealized —

— Avexis Inc 5.2%

Value $31.13M Shares 281,242 Est. Cost $33.55 Unrealized —

ABUS Arbutus Biopharma Corp 4.3%

Value $26.02M Shares 5,151,615 Est. Cost $3.27 Unrealized +79.5%

— Global Blood Therapeutics Inc 4.0%

Value $23.68M Shares 601,683 Est. Cost $39.19 Unrealized —

OSUR OraSure Technologies Inc 2.8%

Value $16.57M Shares 878,452 Est. Cost $13.47 Unrealized +34.5%

BCRX BioCryst Pharmaceuticals Inc 2.8%

Value $16.56M Shares 3,372,674 Est. Cost $7.22 Unrealized -32.9%

— Corium International Inc 2.7%

Value $16.33M Shares 1,699,653 Est. Cost $7.97 Unrealized —

— Agenus Inc 2.4%

Value $14.12M Shares 4,329,816 Est. Cost $7.48 Unrealized —

EW Edwards Lifesciences Corp 2.3%

Value $13.86M Shares 123,000 Est. Cost $36.70 Unrealized 0.0%

VRAYQ Viewray Inc 2.1%

Value $12.48M Shares 1,348,210 Est. Cost $6.34 Unrealized +26.3%

— Myokardia Inc 1.8%

Value $10.85M Shares 257,663 Est. Cost $42.84 Unrealized —

MASI Masimo Corp 1.7%

Value $10.25M Shares 120,900 Est. Cost $66.53 Unrealized +30.4%

— Atara Biotherapeutics Inc 1.7%

Value $10.07M Shares 556,118 Est. Cost $17.06 Unrealized —

— Proteostasis Therapeutics Inc 1.5%

Value $8.745M Shares 1,500,000 Est. Cost $5.83 Unrealized —

— Viveve Medical Inc 1.4%

Value $8.315M Shares 1,672,998 Est. Cost $4.99 Unrealized —

QURE Uniqure NV 1.3%

Value $7.905M Shares 403,524 Est. Cost $15.23 Unrealized 0.0%

VCEL Vericel Corp 1.2%

Value $7.111M Shares 1,304,801 Est. Cost $4.61 Unrealized 0.0%

— Odonate Therapeutics Inc 1.1%

Value $6.768M Shares 297,555 Est. Cost $22.75 Unrealized —

TCMD Tactile Systems Technology Inc 1.0%

Value $6.096M Shares 210,366 Est. Cost $17.26 Unrealized +68.1%

— Oxford Immunotec Global PLC 0.9%

Value $5.25M Shares 375,792 Est. Cost $15.20 Unrealized —

— Bovie Medical Corp 0.8%

Value $4.557M Shares 1,752,611 Est. Cost $3.11 Unrealized —

— Zynerba Pharmaceuticals Inc 0.4%

Value $2.54M Shares 202,859 Est. Cost $8.42 Unrealized —

— Five Prime Therapeutics Inc 0.4%

Value $2.2M Shares 100,377 Est. Cost $21.92 Unrealized —

ARGX argenx NV 0.3%

Value $1.595M Shares 25,260 Est. Cost $21.81 Unrealized —

— Revance Therapeutics Inc 0.1%

Value $824K Shares 23,038 Est. Cost $35.77 Unrealized —

— SENSUS HEATLHCARE INC 0.0%

Value $98,000 Shares 151,400 Est. Cost $0.50 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PTCT	PTC Therapeutics Inc	4,130,115	$68.89M	11.5%	$13.46	+25.7%	COM	69366J200
RGNX	Regenxbio Inc	1,561,210	$51.91M	8.7%	$20.73	+45.4%	COM	75901B107
BMY	Bristol-Myers Squibb Co	839,452	$51.44M	8.6%	$42.11	+10.3%	COM	110122108
ALNY	Alnylam Pharmaceuticals Inc	358,774	$45.58M	7.6%	$75.05	+67.4%	COM	02043Q107
—	Dicerna Pharmaceuticals Inc	5,035,662	$44.14M	7.4%	$10.56	—	COM	253031108
—	Achillion Pharmaceuticals Inc	13,546,902	$39.02M	6.5%	$3.82	—	COM	00448Q201
—	La Jolla Pharmaceutical Co	1,063,170	$34.21M	5.7%	$25.47	—	COM PAR $.0001 2	503459604
—	Avexis Inc	281,242	$31.13M	5.2%	$33.55	—	COM	05366U100
ABUS	Arbutus Biopharma Corp	5,151,615	$26.02M	4.3%	$3.27	+79.5%	COM	03879J100
—	Global Blood Therapeutics Inc	601,683	$23.68M	4.0%	$39.19	—	COM	37890U108
OSUR	OraSure Technologies Inc	878,452	$16.57M	2.8%	$13.47	+34.5%	COM	68554V108
BCRX	BioCryst Pharmaceuticals Inc	3,372,674	$16.56M	2.8%	$7.22	-32.9%	COM	09058V103
—	Corium International Inc	1,699,653	$16.33M	2.7%	$7.97	—	COM	21887L107
—	Agenus Inc	4,329,816	$14.12M	2.4%	$7.48	—	COM NEW	00847G705
EW	Edwards Lifesciences Corp	123,000	$13.86M	2.3%	$36.70	0.0%	COM	28176E108
VRAYQ	Viewray Inc	1,348,210	$12.48M	2.1%	$6.34	+26.3%	COM	92672L107
—	Myokardia Inc	257,663	$10.85M	1.8%	$42.84	—	COM	62857M105
MASI	Masimo Corp	120,900	$10.25M	1.7%	$66.53	+30.4%	COM	574795100
—	Atara Biotherapeutics Inc	556,118	$10.07M	1.7%	$17.06	—	COM	046513107
—	Proteostasis Therapeutics Inc	1,500,000	$8.745M	1.5%	$5.83	—	COM	74373B109
—	Viveve Medical Inc	1,672,998	$8.315M	1.4%	$4.99	—	COM NEW	92852W204
QURE	Uniqure NV	403,524	$7.905M	1.3%	$15.23	0.0%	SHS	N90064101
VCEL	Vericel Corp	1,304,801	$7.111M	1.2%	$4.61	0.0%	COM	92346J108
—	Odonate Therapeutics Inc	297,555	$6.768M	1.1%	$22.75	—	COM	676079106
TCMD	Tactile Systems Technology Inc	210,366	$6.096M	1.0%	$17.26	+68.1%	COM	87357P100
—	Oxford Immunotec Global PLC	375,792	$5.25M	0.9%	$15.20	—	ORD SHS	G6855A103
—	Bovie Medical Corp	1,752,611	$4.557M	0.8%	$3.11	—	COM	10211F100
—	Zynerba Pharmaceuticals Inc	202,859	$2.54M	0.4%	$8.42	—	COM	98986X109
—	Five Prime Therapeutics Inc	100,377	$2.2M	0.4%	$21.92	—	COM	33830X104
ARGX	argenx NV	25,260	$1.595M	0.3%	$21.81	—	SPONSORED ADR	04016X101
—	Revance Therapeutics Inc	23,038	$824K	0.1%	$35.77	—	COM	761330109
—	SENSUS HEATLHCARE INC	151,400	$98,000	0.0%	$0.50	—	*W EXP 06/08/201	81728J117